TipRanks
Go Ultimate55% OFF

Ravi Anand Insider Profile

4 Followers

Ravi Anand, Chief Medical Officer at Newron Pharmaceuticals SpA, holds ― shares in Newron Pharmaceuticals SpA (Ticker: NWPHF). Most recently, Ravi Anand Bought 1,999 shares of Newron Pharmaceuticals SpA on Aug 12, 2026 for an estimated value of $23.95K.

Ravi Anand's Trading History

NWPHF
Newron Pharmaceuticals SpA
Aug 12, 2026Chief Medical OfficerInformative Buy23.95K―
NWPHF
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 12, 2026Informative BuyCHF23.95K1,999CHF11.980.00%―
May 11, 2022Informative Buy€14.25K9,831€1.450.00%―
Nov 30, 2020Informative BuyCHF20.00K10,000CHF2.00+42.70%―

You May Also Like

Ravi Anand insider profile FAQ

What is the percentage of profitable transactions made by Ravi Anand?
The percentage of profitable transactions made by Ravi Anand is 33%.
What is the average return per transaction made by Ravi Anand?
The average return per transaction made by Ravi Anand is 14.20%.
What stocks does Ravi Anand hold?
Ravi Anand holds: NWPHF stocks.
What was Ravi Anand’s latest transaction?
Ravi Anand’s latest transaction was an Informative Buy of $23.95K.
What was Ravi Anand's most profitable transaction?
Ravi Anand’s most profitable transaction was an Informative Buy of NWPHF stock on November 30, 2020. The return on the trade was 42.70%.
What is Ravi Anand's role in Newron Pharmaceuticals SpA?
Ravi Anand's role in Newron Pharmaceuticals SpA is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.